| 注册
首页|期刊导航|中国医学创新|西黄胶囊联合生大黄对子宫颈癌根治术后盆腔淋巴囊肿的影响

西黄胶囊联合生大黄对子宫颈癌根治术后盆腔淋巴囊肿的影响

纪贤芬

中国医学创新2024,Vol.21Issue(30):25-28,4.
中国医学创新2024,Vol.21Issue(30):25-28,4.DOI:10.3969/j.issn.1674-4985.2024.30.006

西黄胶囊联合生大黄对子宫颈癌根治术后盆腔淋巴囊肿的影响

Influence of Xihuang Capsules Combined with Raw Rhubarb on Pelvic Lymphocyst after Radical Resection of Cervical Cancer

纪贤芬1

作者信息

  • 1. 江西省妇幼保健院肿瘤科 江西 南昌 330000
  • 折叠

摘要

Abstract

Objective:To explore the influence of Xihuang Capsules combined with raw rhubarb on pelvic lymphocyst(PL)after radical resection of cervical cancer.Method:From September 2021 to September 2023,80 patients with PL of damp-heat stasis accumulation type after radical resection of cervical cancer in Jiangxi Maternal and Child Health Hospital were enrolled and classified into two groups according to the random number table method,with 40 cases in each group.The control group was treated with raw rhubarb,and the observation group was given Xihuang Capsules combined with raw rhubarb.The clinical efficacy on the 90th day after surgery and pain status[visual analogue scale(VAS)],TCM syndrome score and inflammatory factor[C reactive protein(CRP)]before treatment and after 30 days and 90 days of treatment were compared between both groups.Result:After 90 days of treatment,the clinical efficacy in observation group was significantly higher than that in control group(P<0.05).After 30 and 90 days of treatment,the VAS score,TCM syndrome score and CRP level in observation group and control group were significantly decreased compared with those before treatment(P<0.05),and those in observation group were lower than those in control group(P<0.05).Conclusion:Xihuang Capsules combined with raw rhubarb has an exact efficacy in the treatment of PL patients after radical resection of cervical cancer,and it can relieve the clinical symptoms of patients.

关键词

子宫颈癌根治术/盆腔淋巴囊肿/西黄胶囊/生大黄

Key words

Radical resection of cervical cancer/Pelvic lymphocyst/Xihuang Capsules/Raw rhubarb

引用本文复制引用

纪贤芬..西黄胶囊联合生大黄对子宫颈癌根治术后盆腔淋巴囊肿的影响[J].中国医学创新,2024,21(30):25-28,4.

基金项目

江西省卫生健康委科技计划(普通科技计划)项目(202310945) (普通科技计划)

中国医学创新

1674-4985

访问量0
|
下载量0
段落导航相关论文